NCT03803397View on ClinicalTrials.gov

Arm 1: Lysate Pulsed Dendritic Cells (PV-001-DC) in Patients With Melanoma

PHASE1UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

August 30, 2024

Study Completion Date

December 31, 2024

Conditions
Metastatic Melanoma
Interventions
BIOLOGICAL

PV-001-DC

Patient-specific cellular therapeutic for cancer immunotherapy

Sponsors
All Listed Sponsors
lead

PrimeVax Immuno-Oncology Inc.

INDUSTRY